{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:14:46Z","timestamp":1789596886477,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":60,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.ctarc.2021.100347","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T14:59:34Z","timestamp":1615129174000},"page":"100347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Chemotherapy use in early stage anal canal squamous cell carcinoma and its impact on long-term overall survival,,,"],"prefix":"10.1016","volume":"27","author":[{"given":"Deanna L","family":"Huffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thejus T","family":"Jayakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany L","family":"Vannatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulabh K","family":"Monga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene G","family":"Finley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V","family":"Kirichenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney E","family":"Wegner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ctarc.2021.100347_bib0001","doi-asserted-by":"crossref","first-page":"852","DOI":"10.6004\/jnccn.2018.0060","article-title":"Anal Carcinoma, Version 2.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Benson","year":"2018","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.ctarc.2021.100347_bib0002","first-page":"7","article-title":"Recent advances in the management of anal cancer","author":"Symer","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.ctarc.2021.100347_bib0003","article-title":"Centers for disease control and prevention: how many cancers are linked with HPV each year?","year":"2017","journal-title":"HPV Cancer"},{"issue":"8","key":"10.1016\/j.ctarc.2021.100347_bib0004","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1586\/14737140.2014.919861","article-title":"Optimal management of squamous cell carcinoma of the anal canal: where are we now?","volume":"14","author":"Eng","year":"2014","journal-title":"Expert Rev. Anticancer. Ther."},{"issue":"10","key":"10.1016\/j.ctarc.2021.100347_bib0005","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/ans.14745","article-title":"Anal squamous cell carcinoma: are we improving outcomes?","volume":"88","author":"Mackowski","year":"2018","journal-title":"ANZ J Surg"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100347_bib0006","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: a preliminary report","volume":"17","author":"Nigro","year":"1974","journal-title":"Dis. Colon. Rectum"},{"issue":"9","key":"10.1016\/j.ctarc.2021.100347_bib0007","first-page":"989","article-title":"Screening for anal cancer precursors among patients living with HIV in the absence of national guidelines: practitioners' perspectives","volume":"30","author":"Koskan","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"36","key":"10.1016\/j.ctarc.2021.100347_bib0008","doi-asserted-by":"crossref","first-page":"13052","DOI":"10.3748\/wjg.v20.i36.13052","article-title":"Anal squamous cell carcinoma: an evolution in disease and management","volume":"20","author":"Osborne","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100347_bib0009","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomized, phase 3, open-label, 2\u00a0\u00d7\u00a02 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100347_bib0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The national cancer data base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100347_bib0011","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100347_bib0012","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/03007995.2018.1441817","article-title":"Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma","volume":"34","author":"Oweira","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100347_bib0013","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0029-1223843","article-title":"Clinical trials in the management of anal cancer","volume":"22","author":"Sana","year":"2009","journal-title":"Clin. Colon. Rectal. Surg."},{"issue":"9034","key":"10.1016\/j.ctarc.2021.100347_bib0014","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research","volume":"348","year":"1996","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100347_bib0015","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.ctarc.2021.100347_bib0016","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ctarc.2021.100347_bib0017","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.critrevonc.2018.01.007","article-title":"Treatment of squamous cell carcinoma of the anal canal: a new strategies with anti-EGFR therapy and immunotherapy","volume":"123","author":"Casadei Gardini","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"7","key":"10.1016\/j.ctarc.2021.100347_bib0018","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1200\/JCO.2016.69.1667","article-title":"Cetuximab plus chemoradiotherapy in immunocompetent patients with anal carcinoma: a Phase II eastern cooperative oncology group-American college of radiology imaging network cancer research group trial (E3205)","volume":"35","author":"Garg","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2021.100347_bib0019","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.2016.69.1642","article-title":"Cetuximab plus chemoradiotherapy for HIV-associated anal carcinoma: a phase II AIDS malignancy consortium trial","volume":"35","author":"Sparano","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2021.100347_bib0020","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1470-2045(17)30104-3","article-title":"Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study","volume":"18","author":"Morris","year":"2017","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100347_bib0021","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/annonc\/mdx029","article-title":"Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal","volume":"28","author":"Ott","year":"2017","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2021.100347_bib0022","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1158\/1078-0432.CCR-19-1513","article-title":"A phase II, prospective, randomized, multicenter, open-label study of GX-188E, an HPV DNA vaccine, in patients with cervical intraepithelial neoplasia 3","volume":"26","author":"Choi","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.ctarc.2021.100347_bib0023","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1134\/S0006297919070101","article-title":"Therapeutic vaccines against human papilloma viruses: achievements and prospects","volume":"84","author":"Vonsky","year":"2019","journal-title":"Biochemistry (Mosc)"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100347_bib0024","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamasurg.2017.3151","article-title":"Management of stage I squamous cell carcinoma of the anal canal [published correction appears in JAMA Surg. 2018 May 23;153(7):692]","volume":"153","author":"Chai","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ctarc.2021.100347_bib0025","series-title":"A Randomized Phase II Study De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)","author":"Dorth","year":"2019"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221000460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221000460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:23:06Z","timestamp":1762842186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294221000460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":25,"alternative-id":["S2468294221000460"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100347","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy use in early stage anal canal squamous cell carcinoma and its impact on long-term overall survival,,,","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100347"}}